Coagulant and anticoagulant activities of Bothrops lanceolatus (Fer de lance) venom

Toxicon

Volumn 39, Issue 2-3, 2001, Pages 371-375

  Lôbo De Araújo, Albetiza ^a   Kamiguti, Aura ^b   Bon, Cassian ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ANTICOAGULANT AGENT; ANTITHROMBIN III; CITRIC ACID; COAGULATING AGENT; FIBRINOGEN; HEPARIN; PHOSPHOLIPASE A2; PROTEINASE INHIBITOR; SNAKE VENOM;

ANTICOAGULATION; BLOOD CLOTTING; BOTHROPS LANCEOLATUS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FIBRINOGENOLYSIS; FIBRINOLYSIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRIORITY JOURNAL; PURIFICATION; SNAKE;

BOTHROPS; BOTHROPS ATROX;

EID: 0343442450     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(00)00139-2     Document Type: Conference Paper

References (27)

1. 2. Thromb. Haemost. 45:1981;82-85.
2. Eagle H. The coagulation of blood by snake venoms and its physiologic significance. J. Exp. Med. 65:1937;613-639.
3. Henriques O.B., Mandelbaum F.R., Henriques S.A. Blood clotting by the venom of Bothrops jararaca. Nature. 183:1959;114-115.
4. Hoffmann H., Bon C. Blood coagulation induced by the venom of Bothrops atrox. Identification, purification and properties of a prothrombin activator. Biochemistry. 26:1987;772-780.
5. Hoffmann H., Bon C. Blood coagulation induced by the venom of Bothrops atrox. Identification, purification and properties of two factor X activators. Biochemistry. 26:1987;780-787.
6. Janszky B. Effect of calcium on the clotting of fibrinogen by snake venoms. Buckley E.E., Porges N. Venoms. 1956;237-241 American Association for the Advancement of Science, Washington, DC.
7. Jespersen J., Astrup T. A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis. 13:1983;301-315.
8. Kaiser I.I., Gutiérrez J.M., Plummer D., Aird S.D., Odell G.V. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch. Biochem. Biophys. 278:1990;319-325.
9. Kamiguti A., Matsunaga S., Spir M., Sano-Martins I.S., Nahas L. Alterations of the blood coagulation system after accidental human inoculation by Bothrops jararaca venom. Braz. J. Med. Biol. Res. 19:1986;199-204.
10. Kamiguti A., Souza e Silva M.C.C., Morena P., Nahas L. The anticoagulant effect of Bothrops castelnaudi snake venom (Castelnaud's pit viper). Toxicon. 23:1985;383-391.
11. Kornalick F. The influence of snake venom enzymes on blood coagulation. Pharmacol. Ther. 29:1985;353-405.
12. Lôbo de Araújo A., Donato J.L., Bon C. Purification from Bothrops lanceolatus (Fer de lance) venom of a fibrino(geno)lytic enzyme with esterolytic activity. Toxicon. 36:1998;745-758.
13. 2 activity by a colorimetric assay using a pH indicator. Toxicon. 25:1987;1181-1188.
14. 2 from Bothrops lanceolatus venom: purification and molecular, enzymatic and pharmacological properties. Toxicon. 32:1994;1069-1081.
15. Maruyama M., Kamiguti A.S., Cardoso J.L.C., Sano Martins, I.S., Chudzinski A.M., Santoro M.L., Morena P., Tomy S.C., Antonio L.C., Mihara M., Kelen E.M.A. Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (jararaca). Thromb. Haemost. 63:1990;449-453.
16. 2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va. Eur. J. Biochem. 237:1996;778-785.
17. Nahas L., Denson K.W.E., MacFarlane R.G. A study of the coagulant action of eight snake venoms. Thromb. Diath. Haemorrh. 12:1964;355-367.
18. Nahas L., Kamiguti A.S., Barros M.A.R. Thrombin-like and factor X-activator components of Bothrops snake venoms. Thromb. Haemost. 41:1979;314-328.
19. Rosenberg P. The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. Harris J.B. Natural Toxins. 1986;129-174 Oxford University Press, Oxford.
20. Rosenfeld G., Hampe O.G., Kelen E.M.A. Coagulation and fibrinolytic activity of animal venoms: determination of coagulant and fibrinolytic index of different species. Mem. Inst. Butantan. 29:1959;143-148.
21. Rosenfeld G., Nahas L., Kelen E.M.A. Coagulant, proteolytic and hemolytic properties of some snake venoms. Bucherl W., Buckley E., Deulofeu V. Venomous Animals and their Venoms. 1:1968;229-273 Academic Press, New York.
22. Selistre H.S., Giglio J.R. Isolation and characterization of a thrombin-like enzyme from the venom of the snake Bothrops insularis (jararaca ilhoa). Toxicon. 25:1987;1135-1144.
23. Stocker K., Christ W., Leloup P. Characterization of the venoms of various Bothrops species by immunoelectrophoresis and reaction with fibrinogen agarose. Toxicon. 12:1974;415-417.
24. Stocker K., Fischer H., Meier J. Thrombin-like snake venom proteinases. Toxicon. 20:1982;265-273.
25. Thomas L., Tyburn B., Bucher B., Pecout F., Ketterlé J., Riex D., Smadja D., Guarnier D., Plumelle Y. Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Am. J. Trop. Med. Hyg. 52:1995;419-426.
26. Thomas L., Tyburn B., Ketterlé J., Rieux D., Guarnier D., Smadja D. Troubles de la coagulation et thromboses induites par la morsure de serpent (Bothrops lanceolatus) chez l'homme em Martinique. Réanim. Urgence. 3:1994;25-30.
27. Thomas, L., Tyburn, B., Ketterlé, J., Biao, T., Mehdaoui, H., Morauie, V., Rouvel, C., Plummelle, Y., Bucher, B., Canonge, D., Marie-Nelly, C.A., Lang, J. and Other Members of the Research Group on Snake Bite in Martinique, 1998. Prognostic significant of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique. Trans. R. Soc. Trop. Med. Hyg. 92, 542-545.